The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor and c-Src interactions in breast cancer
Open accessAbstract
Both the non-receptor tyrosine kinase, c-Src, and members of the epidermal growth factor (EGF) receptor family are overexpressed in high percentages of human breast cancers. Because these molecules are plasma membrane-associated and involved in mitogenesis, it has been speculated that they function in concert with one another to promote breast cancer development and progression. Evidence to date supports a model wherein c-Src potentiates the survival, proliferation and tumorigenesis of EGF receptor family members, in part by associating with them. Phosphorylation of the EGF receptor by c-SRC is also critical for mitogenic signaling initiated by the EGF receptor itself, as well as by several G-protein coupled receptors (GPCRs), a cytokine receptor, and the estrogen receptor. Thus, c-Src appears to have pleiotropic effects on cancer cells by modulating the action of multiple growth-promoting receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,814
Ellis, L., Clauser, E., Morgan, D. O., Edery, M., Roth, R. A., & Rutter, W. J. (1986) · Cell · doi:10.1016/0092-8674(86)90786-5 · Cited by 1,070
Baselga, J. M., Norton, L., Albanell, J., Kim, Y. M., & Mendelsohn, J. M. (1998) · PubMed · Cited by 996
The biology of erbB-2/nue/HER-2 and its role in cancer
Hynes, N. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90012-4 · Cited by 971
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959
Signal characteristics of G protein-transactivated EGF receptor
Daub, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7032 · Cited by 658
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Biscardi, J. S., Maa, M.-C., Tice, D. A., Cox, M. E., Leu, T.-H., & Parsons, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8335 · Cited by 649
Self-citationStat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Luttrell, L. M., Hawes, B. E., van Biesen, T., Luttrell, D. K., Lansing, T. J., & Lefkowitz, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19443 · Cited by 525
Activation of the Protein Kinase ERK5/BMK1 by Receptor Tyrosine Kinases
Kamakura, S., Moriguchi, T., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26563 · Cited by 510
Lysophosphatidic acid: G-protein signalling and cellular responses
Moolenaar, W. H., Kranenburg, O., Postma, F. R., & Zondag, G. C. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80059-2 · Cited by 486
Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.
Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., Curtis, S. W., Washburn, T. F., McLachlan, J. A., & Korach, K. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4658 · Cited by 480
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor
Tice, D. A., Biscardi, J. S., Nickles, A. L., & Parsons, S. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1415 · Cited by 472
Self-citationGβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor
Luttrell, L. M., Rocca, G. J. D., van Biesen, T., Luttrell, D. K., & Lefkowitz, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4637 · Cited by 457
Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor
Kato, Y., Tapping, R. I., Huang, S., Watson, M. H., Ulevitch, R. J., & Lee, J.-D. (1998) · Nature · doi:10.1038/27234 · Cited by 436
Epidermal-Growth-Factor-Dependent Transformation by a Human EGF Receptor Proto-Oncogene
Velu, T. J., Beguinot, L., Vass, W. C., Willingham, M. C., Merlino, G. T., Pastan, I., & Lowy, D. R. (1987) · Science · doi:10.1126/science.3500513 · Cited by 433
ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases
Olayioye, M. A., Beuvink, I., Horsch, K., Daly, J. M., & Hynes, N. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17209 · Cited by 367
Wilde, A., Beattie, E. C., Lem, L., Riethof, D. A., Liu, S.-H., Mobley, W. C., Soriano, P., & Brodsky, F. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80578-4 · Cited by 348
Maa, M. C., Leu, T. H., McCarley, D. J., Schatzman, R. C., & Parsons, S. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6981 · Cited by 330
Self-citationIgnar-Trowbridge, D. M. (1993) · Molecular Endocrinology · doi:10.1210/me.7.8.992 · Cited by 325
Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src
Barone, M. V., & Courtneidge, S. A. (1995) · Nature · doi:10.1038/378509a0 · Cited by 309
Ottenhoff-Kalff, A. E., Rijksen, G., van Beurden, E. A., Hennipman, A. H., Michels, A. A., & Staal, G. E. J. (1992) · PubMed · Cited by 306
HEMATOPOIETIC RECEPTOR COMPLEXES
Wells, J. A., & de Vos, A. M. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003141 · Cited by 298
Regulation of STAT‐dependent pathways by growth factors and cytokines
Leaman, D. W., Leung, S., Li, X., & Stark, G. R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.14.9002549 · Cited by 297
EGF receptor in neoplasia and metastasis
Khazaie, K., Schirrmacher, V., & Lichtner, R. B. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00665957 · Cited by 288
Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone
Yamauchi, T., Ueki, K., Tobe, K., Tamemoto, H., Sekine, N., Wada, M., Honjo, M., Takahashi, M., Takahashi, T., Hirai, H., et al. (1997) · Nature · doi:10.1038/36369 · Cited by 285
Involvement of pp60c-src with two major signaling pathways in human breast cancer.
Luttrell, D. K., Lee, A., Lansing, T. J., Crosby, R. M., Jung, K. D., Willard, D., Luther, M., Rodriguez, M., Berman, J., & Gilmer, T. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.83 · Cited by 271
VERBEEK, B. S., VROOM, T. M., ADRIAANSEN-SLOT, S. S., OTTENHOFF-KALFF, A. E., GEERTZEMA, J. G. N., HENNIPMAN, A., & RIJKSEN, G. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199612)180:4<383::aid-path686>3.0.co;2-n · Cited by 270
Roche, S., Koegl, M., & Courtneidge, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9185 · Cited by 265
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
Castoria, G., Barone, M. V., Di Domenico, M., Bilancio, A., Ametrano, D., Migliaccio, A., & Auricchio, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2500 · Cited by 253
Roche, S., Koegl, M., Barone, M. V., Roussel, M. F., & Courtneidge, S. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.1102 · Cited by 244
c-Src, Receptor Tyrosine Kinases, and Human Cancer
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60774-5 · Cited by 243
Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
Muthuswamy, S. K., Siegel, P. M., Dankort, D. L., Webster, M. A., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.735 · Cited by 228
Watson, C., & Miller, W. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.162 · Cited by 226
Stover, D. R., Becker, M., Liebetanz, J., & Lydon, N. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15591 · Cited by 218
Guy, C. T., Muthuswamy, S. K., Cardiff, R. D., Soriano, P., & Muller, W. J. (1994) · Genes & Development · doi:10.1101/gad.8.1.23 · Cited by 203
STAT5 Activation by BCR-Abl Contributes to Transformation of K562 Leukemia Cells
de Groot, R. P., Raaijmakers, J. A. M., Lammers, J.-W. J., Jove, R., & Koenderman, L. (1999) · Blood · doi:10.1182/blood.v94.3.1108.415k07_1108_1112 · Cited by 187
Sartor, C. I., Dziubinski, M. L., Yu, C., Jove, R., & Ethier, S. P. (1997) · PubMed · Cited by 184
The Regulation and Expression of c-myc in Normal and Malignant Cells
Kelly, K. (1986) · Annual Review of Immunology · doi:10.1146/annurev.immunol.4.1.317 · Cited by 184
Biscardi, J. S., Belsches, A. P., & Parsons, S. J. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199804)21:4<261::aid-mc5>3.0.co;2-n · Cited by 165
Self-citationEnglish, J. M., Pearson, G. W., Baer, R. J., & Cobb, M. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3854 · Cited by 151
Luttrell, D. K., Luttrell, L. M., & Parsons, S. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.497-501.1988 · Cited by 149
Self-citationCunnick, J. M., Dorsey, J. F., Standley, T. B., Turkson, J., Kraker, A. J., Fry, D. W., Jove, R., & Wu, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14468 · Cited by 148
Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells.
Shalloway, D. I., Coussens, P. M., & Yaciuk, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7071 · Cited by 140
Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells.
Migliaccio, A., Pagano, M., & Auricchio, F. (1993) · PubMed · Cited by 118
Role of c-Src tyrosine kinase in EGF-induced mitogenesis
Parsons, S. J. (1997) · Frontiers in bioscience · doi:10.2741/a208 · Cited by 117
Self-citationKazansky, A. V., Kabotyanski, E. B., Wyszomierski, S. L., Mancini, M. A., & Rosen, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22484 · Cited by 113
Wilson, L. K., Luttrell, D. K., Parsons, J. T., & Parsons, S. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1536 · Cited by 107
Self-citationEpidermal growth factor receptor expression as a prognostic indicator in breast cancer
Toi, M., Osaki, A., Yamada, H., et al. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90262-c · Cited by 97
Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.
Salh, B., Marotta, A., Matthewson, C., et al. (1999) · PubMed · Cited by 94
Ware, M. F., Tice, D. A., Parsons, S. J., & Lauffenburger, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30185 · Cited by 90
Self-citationFantl, W. J., Escobedo, J. A., & Williams, L. T. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.10.4473-4478.1989 · Cited by 87
Xing, C. (1999) · Carcinogenesis · doi:10.1093/carcin/20.7.1201 · Cited by 58
van der Geer, P., & Hunter, T. R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4698 · Cited by 57
Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity
Muthuswamy, S. K., Siegel, P. M., Dankort, D. L., Webster, M. A., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.735-743.1994 · Cited by 56
Lichtner, R. B., Kaufmann, A. M., Kittmann, A., Rohde-Schulz, B., Walter, J., Williams, L., Ullrich, A., Schirrmacher, V., & Khazaie, K. (1995) · PubMed · Cited by 54
C-Src Activation by ErbB2 Leads to Attachment-Independent Growth of Human Breast Epithelial Cells
Sheffield, L. G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9214 · Cited by 46
Groenen, L. C., Walker, F., Burgess, A. W., & Treutlein, H. R. (1997) · Biochemistry · doi:10.1021/bi9614141 · Cited by 35
Wilson, L. K., Luttrell, D. K., Parsons, J. T., & Parsons, S. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1536-1544.1989 · Cited by 23
Self-citationZhang, H., O’Rourke, D. M., Zhao, H., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201820 · Cited by 21
Research works printed but not linked: 1
- Bolla M, Chedin M, Souvignet C, et al: Estimation of epidermal growth factor receptor in 177 breast cancers: correlation with prognostic factors. Breast Cancer Res Treat. 1990, 16: 97-102. · doi:10.1007/bf01809293
Cited by
Src family kinases in tumor progression and metastasis
Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827
Src kinases as therapeutic targets for cancer
Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700
c-Src and cooperating partners in human cancer
Ishizawar, R., & Parsons, S. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.001 · Cited by 617
Self-citationGritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1752 · Cited by 563
Persistent organochlorinated pesticides and mechanisms of their toxicity
Mrema, E. J., Rubino, F. M., Brambilla, G., Moretto, A., Tsatsakis, A. M., & Colosio, C. (2013) · Toxicology · doi:10.1016/j.tox.2012.11.015 · Cited by 479
Metadata
- Authors
- Biscardi, J. S., Ishizawar, R. C., Silva, C. M., & Parsons, S. J.
- Venue
- Breast Cancer Research
- Published
- 2000-06
- Volume
- 2
- Issue
- 3
- Pages
- 203-10
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W1854123316
- Cited by
- 323
- References
- 64
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.